+1 (704) 266-3234

Global Smart Pills Technology Market - Segmented By Technology, Disease Indication, And Geography - Growth, Trends, And Forecast (2018 - 2023)

Published on: Apr 2018 | From USD $4250 | Published By: MORDOR INTELLIGENCE | Number Of Pages: 105

The global smart pills technology market is expected to register a CAGR of 16% during the forecast period of 2018Ð2023. The smart pill is a wireless capsule that can be swallowed, and with the help of a receiver (worn by patients) and software that analyzes the pictures captured by the smart pill, the physician is effectively able to examine the gastrointestinal tract. Gastrointestinal disorders have become very common, but recently, there has been increasing incidence of colorectal cancer, inflammatory bowel disease, and CrohnÕs disease as well.

Increasing Preference for Minimally Invasive Device

Endoscopy surgeries, being minimally invasive, have become more popular in recent times. Latest studies show that there is an increasing demand for single incision or small incision type of surgery as an alternative to traditional surgeries. As aging patients are susceptible to complications, the usage of minimally invasive procedures is of utmost importance and the need of the hour. There are unexplained situations of bleeding, iron deficiency, abdominal pain, search for polyps, ulcers, and tumors of the small intestine, and inflammatory bowel disease, such as Crohn's disease, where capsule endoscopy diagnoses fare better than traditional endoscopy. Also, as capsule endoscopy is less invasive or non-invasive, as compared to traditional endoscopy, patients are increasingly preferring the usage of capsule endoscopy as it does not require any recovery time, which is driving the smart pill market.
The other factors, such as the increasing incidence of gastrointestinal disorders, technological advancements, and ability to track bodily functions and forewarn potential illness are driving the smart pills technology market.

Potential Health Risks of Smart Pills

There are certain risks associated with smart pills that might restrain their use. A smart pill usually leaves the body within two weeks. Sometimes, the pill might get lodged in the digestive tract rather than exiting the body via normal bowel movements. The risk might be higher in people with a tumor, CrohnÕs disease, or some surgery within that area that lead to narrowing of the digestive tract. CT scan is usually performed in people with high-risk to assess the narrowing of the tract. However, the pill might still be lodged even if the results are negative for the CT scan, which might lead to bowel obstruction and can be removed either by surgery or traditional endoscopy. Smart pills might lead to skin irritation, which results in mild redness and need to be treated topically. It may also lead to capsule aspiration, which involves the capsule going down the wrong pipe and entering the airway instead of the esophagus. This might result in choking and death if immediate bronchoscopic extraction is not performed. Patients with comorbidities related to brain injury or chronic obstructive pulmonary disease may be at a higher risk. So, the health risks associated with the use of smart pills are hindering the smart pills technology market. The other factors, such as increasing cost with technological advancement and ethical constraints are also hindering the market.

United States Leads the Market in North America

In 2017, the United States smart pills technology market held the largest market share in North America due to the presence of high-quality healthcare systems and modern medical technology in the country. Additionally, the growing healthcare policies from the government is likely to contribute towards the growth of the smart pills technology market.

Key Developments in the Market

¥ September 2017: Scientists developed a miniature medical chip called as ATOMS, which can be used in ingestible smart pills to diagnose and treat diseases within the body.
¥ November 2017: The FDA approved the first digital pill called Abilify MyCite.

Major Players: NOVARTIS AG, PROTEUS PHARMACEUTICALS, PHILLIPS, MICROCHIPS, VITALITY, PIXIE SCIENTIFIC, OLYMPUS MEDICAL TECHNOLOGY, GE HEALTHCARE, BOSTON SCIENTIFIC CORPORATION, and GIVEN IMAGING LTD, among others.

Reasons to Purchase the Report

¥ Follow the current and future global smart pills technology market in the developed and emerging markets.
¥ Examining the various perspectives of the market with the help of PorterÕs Five Forces Analysis.
¥ Identify the segment that is expected to dominate the market.
¥ Identify the regions that are expected to witness the fastest growth during the forecast period.
¥ Identify the latest developments, market shares, and strategies employed by the major market players.
¥ 3-month analyst support along with the Market Estimate sheet (in Excel).

Customization of the Report

¥ This report can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.

1. Introduction
1.1 Market Definition
2. Research Methodology
3. Executive Summary
4. Key Inferences
5. Market Overview
5.1 Current Market Scenario
5.2 Porter's Five Forces Analysis
5.2.1 Bargaining Power of Suppliers
5.2.2 Bargaining Power of Consumers
5.2.3 Threat of New Entrants
5.2.4 Threat of Substitute Products and Services
5.2.5 Competitive Rivalry within the Industry
6. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
6.1 Drivers
6.1.1 Increasing Preference for Minimally Invasive Device
6.1.2 Increasing Incidence of Gastrointestinal Disorders
6.1.3 Technological Advancements
6.1.4 Ability to Track Bodily Functions and Forewarn Potential Illness
6.2 Restraints
6.2.1 Increasing Cost with Technological Advancement
6.2.2 Ethical Constraints
6.2.3 Potential Health Risks
6.3 Opportunities
6.4 Key Challenges
7. Market Segmentation
7.1 By Technology
7.1.1 Capsule Endoscopy
7.1.1.1 Small Bowel Video Capsule Endoscopy
7.1.1.2 Colon Capsule Endoscopy
7.1.2 Patient Monitoring
7.1.3 Drug Delivery
7.2 By Disease Indication
7.2.1 Occult GI Bleeding
7.2.2 CrohnÕs Disease
7.2.3 Small Bowel Tumors
7.2.4 Celiac Disease
7.2.5 Inherited Polyposis Syndromes
7.2.6 Others
7.3 By Geography
7.3.1 North America
7.3.1.1 United States
7.3.1.2 Canada
7.3.1.3 Mexico
7.3.2 Europe
7.3.2.1 France
7.3.2.2 Germany
7.3.2.3 United Kingdom
7.3.2.4 Italy
7.3.2.5 Spain
7.3.2.6 Rest of Europe
7.3.3 Asia-Pacific
7.3.3.1 China
7.3.3.2 Japan
7.3.3.3 India
7.3.3.4 Australia & New Zealand
7.3.3.5 South Korea
7.3.3.6 Rest of Asia-Pacific
7.3.4 Middle East & Africa
7.3.4.1 GCC
7.3.4.2 South Africa
7.3.4.3 Rest of the Middle East & Africa
7.3.5 South America
7.3.5.1 Brazil
7.3.5.2 Argentina
7.3.5.3 Rest of South America
8. Competitive Landscape
8.1 Mergers & Acquisition Analysis
8.2 Agreements, Collaborations, and Partnerships
8.3 New Products Launches
9. Key Players
9.1 Boston Scientific Corporation
9.2 GE Healthcare
9.3 Given Imaging Ltd
9.4 Microchips
9.5 Novartis AG
9.6 Olympus Medical Technology
9.7 Phillips
9.8 Pixie Scientific
9.9 Proteus Pharmaceuticals
9.10 Vitality
*List not Exhaustive
10. Future of the Market
11. Disclaimer

SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.

PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.

MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.

EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.

REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.

Please Choose License Type

USD $4250
USD $4500
USD $7000
USD $8750
Offer

Why Us

  • Why Us In-depth database
    Our Report’s database covers almost all topics of all regions over the Globe..
  • Why Us Recognised publishing sources
    Tie ups with top publishers around the globe.
  • Why Us Customer Support
    Complete pre and post sales support.
  • Why Us Safe & Secure
    Complete secure payment process.